当前位置:首页 - 行情中心 - 皓元医药(688131) - 财务分析 - 现金流量表

皓元医药

(688131)

  

流通市值:149.98亿  总市值:149.98亿
流通股本:2.12亿   总股本:2.12亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,995,462,290.691,286,991,589.82551,423,146.772,282,090,487.33
  收到的税费返还47,636,291.1210,550,084.596,393,996.2629,749,559.94
  收到其他与经营活动有关的现金53,081,290.4844,555,940.8523,618,227.6948,177,460.86
  经营活动现金流入小计2,096,179,872.291,342,097,615.26581,435,370.722,360,017,508.13
  购买商品、接受劳务支付的现金960,999,728.75657,540,666.17285,102,550.09847,542,881.66
  支付给职工以及为职工支付的现金686,018,543.35458,347,479.04206,972,753.68771,241,346.76
  支付的各项税费176,617,051.42123,794,738.7959,721,090.17141,755,834.23
  支付其他与经营活动有关的现金177,965,154.83112,845,620.7762,140,653.21217,517,187.17
  经营活动现金流出小计2,001,600,478.351,352,528,504.77613,937,047.151,978,057,249.82
  经营活动产生的现金流量净额94,579,393.94-10,430,889.51-32,501,676.43381,960,258.31
二、投资活动产生的现金流量:
  收回投资收到的现金3,293,000,0001,999,000,0001,069,000,00023,000,000
  取得投资收益收到的现金7,635,882.075,431,545.642,787,739.7412,887.67
  处置固定资产、无形资产和其他长期资产收回的现金净额2,306,477.592,306,477.592,306,477.596,344,531.85
  投资活动现金流入小计3,302,942,359.662,006,738,023.231,074,094,217.3329,357,419.52
  购建固定资产、无形资产和其他长期资产支付的现金175,041,970.9597,778,461.6188,557,176.63304,462,662.44
  投资支付的现金2,904,500,0001,638,500,000922,500,000499,748,947.2
  取得子公司及其他营业单位支付的现金---8,800,000
  投资活动现金流出小计3,079,541,970.951,736,278,461.611,011,057,176.63813,011,609.64
  投资活动产生的现金流量净额223,400,388.71270,459,561.6263,037,040.7-783,654,190.12
三、筹资活动产生的现金流量:
  吸收投资收到的现金57,457,667.625,553,658-44,017,353.85
  其中:子公司吸收少数股东投资收到的现金---34,000,000
  取得借款收到的现金643,547,451.5467,730,500.35291,805,529.861,589,558,358.36
  收到其他与筹资活动有关的现金16,356.08---
  筹资活动现金流入小计701,021,475.18493,284,158.35291,805,529.861,633,575,712.21
  偿还债务支付的现金407,312,860.5235,907,509.17118,165,086.88737,749,112.43
  分配股利、利润或偿付利息支付的现金52,999,935.8145,771,939.866,348,625.9447,043,968.61
  支付其他与筹资活动有关的现金36,972,541.6424,726,039.1912,358,912.9457,304,104.22
  筹资活动现金流出小计497,285,337.95306,405,488.22136,872,625.76842,097,185.26
  筹资活动产生的现金流量净额203,736,137.23186,878,670.13154,932,904.1791,478,526.95
四、汇率变动对现金及现金等价物的影响8,282,087.8514,329,706.168,134,951.467,845,113.98
五、现金及现金等价物净增加额529,998,007.73461,237,048.4193,603,219.83397,629,709.12
  加:期初现金及现金等价物余额873,095,672.73873,095,672.73873,095,672.73475,465,963.61
  期末现金及现金等价物余额1,403,093,680.461,334,332,721.131,066,698,892.56873,095,672.73
补充资料:
  净利润-148,696,287.31-197,930,034.58
  资产减值准备-60,966,824.59-131,359,593.72
  固定资产和投资性房地产折旧-52,860,352.82-110,815,258.91
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-52,860,352.82-110,815,258.91
  无形资产摊销-4,686,024.19-9,014,639.61
  长期待摊费用摊销-19,851,714.33-28,271,022.01
  处置固定资产、无形资产和其他长期资产的损失--616,971.72-567,191.03
  固定资产报废损失---17,909.22
  公允价值变动损失--212,602.74--150,068.49
  财务费用-18,087,016.02-36,410,144.92
  投资损失--1,247,313.04-13,757,656.87
  递延所得税--22,617,129.06--45,398,098.93
  其中:递延所得税资产减少--22,617,129.06--30,614,828.23
    递延所得税负债增加----14,783,270.7
  存货的减少--215,153,545.07--145,864,424.76
  经营性应收项目的减少--87,436,239.4--104,595,289.47
  经营性应付项目的增加--30,183,738.18-65,205,154.69
  其他-20,212,972.46-25,395,817.89
  现金的期末余额-1,334,332,721.13-873,095,672.73
  减:现金的期初余额-873,095,672.73-475,465,963.61
  现金及现金等价物的净增加额-461,237,048.4-397,629,709.12
公告日期2025-10-312025-08-292025-04-302025-03-28
审计意见(境内)标准无保留意见
TOP↑